BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 27
• 28
• 29

• Business

  Denator AB Expands Asian Distributor Network as Number of Labs Adopting Heat-Stabilization Technology Continues to Grow

  December 13, 2011

   · 

  1 min read
• Drug Development

  Ligand Pharmaceuticals Inc. Announces Positive Preclinical Data on Small-Molecule GCSF Receptor Agonist at the 53rd Annual Meeting of the American Society of Hematology

  December 13, 2011

   · 

  1 min read
• Drug Development

  Telik, Inc. Announces Phase 1 Results of a Multicenter Study of Telintra(R) (Ezatiostat Hydrochloride, TLK199) in Combination with Revlimid(R) (Lenalidomide) in Patients with Myelodysplastic Syndrome

  December 13, 2011

   · 

  7 min read
• Business

  BrainScope Company, Inc. Awarded $7.5 Million Department of Defense Research Contract for Assessment of Traumatic Brain Injury

  December 13, 2011

   · 

  1 min read
• Mauna Kea Technologies Announces the Publication of a Study Confirming the Value of the Cellvizio® System in Colorectal Cancer Follow-Up

  December 13, 2011

   · 

  5 min read
• Drug Development

  Top-Line Phase 2 Data Indicate Repros Therapeutics Inc.'s Androxal(R) Normalizes Testicular Function in Men With Type 2 Diabetes

  December 13, 2011

   · 

  5 min read
• Drug Development

  Celgene Corporation Release: Phase II Study Evaluates Clinical Benefit of Pomalidomide in Heavily Pre-Treated Patients with Multiple Myeloma

  December 13, 2011

   · 

  1 min read
• ChinaBio Today Release: China Will Regulate TCMs to Improve Their Purity

  December 13, 2011

   · 

  1 min read
• Genetown

  Alnylam Pharmaceuticals Scientists Present New Data on RNAi Therapeutics at 53rd American Society of Hematology Annual Meeting

  December 13, 2011

   · 

  1 min read
• Drug Development

  Millennium: The Takeda Oncology Company Release: Overall Survival Benefit with VELCADE® Based Therapy in Previously Untreated Multiple Myeloma Patients Maintained After Five Year Follow-Up

  December 13, 2011

   · 

  1 min read